MICHELLE SHAUGHNESSY: Open Payments
NPI 1326714874 · ANTHEM, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$315 in 15 payments from 9 companies in 2025. Trend: 2023 $1,041 · 2024 $1,199 · 2025 $315
Food & beverage: $315
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 5 | $80 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| GENZYME CORPORATION | 1 | $33 |
| Janssen Biotech, Inc. | 2 | $31 |
| ABBVIE INC. | 1 | $27 |
| Incyte Corporation | 1 | $27 |
| Lilly USA, LLC | 1 | $23 |
| Amgen Inc. | 1 | $16 |
Products named: VTAMA, DUPIXENT, TREMFYA, RINVOQ, OPZELURA, BLU-U, TALTZ, Odomzo.
Industry payments across AZ — which companies pay providers there.
